Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action Plan
FDA releases Biosimilars Action Plan to address competition and affordability for biologics and biosimilar products.
